Upload
razib-alam
View
221
Download
0
Embed Size (px)
Citation preview
8/2/2019 Contrast Echo Final
1/80
Contrast Echocardiography
8/2/2019 Contrast Echo Final
2/80
8/2/2019 Contrast Echo Final
3/80
8/2/2019 Contrast Echo Final
4/80
8/2/2019 Contrast Echo Final
5/80
8/2/2019 Contrast Echo Final
6/80
8/2/2019 Contrast Echo Final
7/80
8/2/2019 Contrast Echo Final
8/80
8/2/2019 Contrast Echo Final
9/80
8/2/2019 Contrast Echo Final
10/80
8/2/2019 Contrast Echo Final
11/80
Contrast Echocardiography
Left ventricular opacification
Myocardial perfusion Assessment of reperfusion andmyocardial viability
8/2/2019 Contrast Echo Final
12/80
Contrast Echocardiography
Improved endocardial border
delineation reduced inter- and intra-observer variability
improved detection of regional
wall motion abnormalities
improved calculation of LVvolumes and ejection fraction
8/2/2019 Contrast Echo Final
13/80
Contrast EchocardiographyInter-institutional agreement according to image quality
Hoffmann et al.J Am Coll Cardiol1996;27:330
8/2/2019 Contrast Echo Final
14/80
Contrast Echocardiography
8/2/2019 Contrast Echo Final
15/80
Contrast Echocardiography
8/2/2019 Contrast Echo Final
16/80
Contrast EchocardiographyNA, 67 y.o. male
8/2/2019 Contrast Echo Final
17/80
Contrast EchocardiographyNA, 67 y.o. male
8/2/2019 Contrast Echo Final
18/80
Contrast EchocardiographyEffect of left ventricular opacification on accuracy of DbE
Dolan et al.Am Heart J2001;142:908
8/2/2019 Contrast Echo Final
19/80
Contrast Echocardiography
Left ventricular opacification
Myocardial perfusion Assessment of reperfusion andmyocardial viability
8/2/2019 Contrast Echo Final
20/80
Contrast EchocardiographyReal-time perfusion imaging using power modulation
8/2/2019 Contrast Echo Final
21/80
Contrast EchocardiographyMCE versusMIBI for assessment of myocardial blood volume
Wei et al.Am J Physiol2001,280:H1896
8/2/2019 Contrast Echo Final
22/80
How do we get from myocardial bloodvolume to myocardial blood flow ?
DYNAMIC IMAGING
8/2/2019 Contrast Echo Final
23/80
Contrast EchocardiographyQuantification of myocardial blood flow
8/2/2019 Contrast Echo Final
24/80
Contrast EchocardiographyReal-time perfusion imaging using power modulation
Van Camp et al.,JASE2003;16:263
8/2/2019 Contrast Echo Final
25/80
Contrast EchocardiographyReal-time perfusion imaging using power modulation
Van Camp et al.,JASE2003;16:263
8/2/2019 Contrast Echo Final
26/80
Contrast EchocardiographyReal-time perfusion imaging using power modulation
Van Camp et al.,JASE2003;16:263
8/2/2019 Contrast Echo Final
27/80
Contrast EchocardiographyReal-time perfusion imaging using power modulation
Van Camp et al.,JASE2003;16:263
8/2/2019 Contrast Echo Final
28/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
29/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
DIPYRIDAMOLEMCE
8/2/2019 Contrast Echo Final
30/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
31/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
32/80
Contrast EchocardiographyDipyridamole real-time PowerModulation
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
33/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
34/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
35/80
Contrast EchocardiographyMN, 50 y.o. male
Peltier et al.JACC2004;43:257
8/2/2019 Contrast Echo Final
36/80
Contrast EchocardiographyDipyridamole RTCE: Prognostic implications
Tsusui et al.JCirculation 2005;112:1444
8/2/2019 Contrast Echo Final
37/80
8/2/2019 Contrast Echo Final
38/80
Contrast EchocardiographyT.V.H. - F - 46 year old
10.43 am: ECG
8/2/2019 Contrast Echo Final
39/80
Contrast EchocardiographyT.V.H. - F - 46 year old
11.43 amCoronary angiography
8/2/2019 Contrast Echo Final
40/80
8/2/2019 Contrast Echo Final
41/80
8/2/2019 Contrast Echo Final
42/80
Contrast EchocardiographyT.V.H. - F - 46 year old
11.53 amDirect angioplasty and stenting
8/2/2019 Contrast Echo Final
43/80
8/2/2019 Contrast Echo Final
44/80
8/2/2019 Contrast Echo Final
45/80
Contrast EchocardiographyAssessment of the no-reflow phenomenon by i.c.MCE
Ito et al. Circulation 1992;85:1699.
8/2/2019 Contrast Echo Final
46/80
8/2/2019 Contrast Echo Final
47/80
8/2/2019 Contrast Echo Final
48/80
8/2/2019 Contrast Echo Final
49/80
8/2/2019 Contrast Echo Final
50/80
Contrast EchocardiographyDetection of myocardial viability with intravenousMCE
Swinburn et al.J Am Coll Cardiol2001;38:19.
8/2/2019 Contrast Echo Final
51/80
Contrast EchocardiographyContrast Echocardiography
To DiagnoseTo DiagnoseAcute Myocardial InfarctionAcute Myocardial Infarction
8/2/2019 Contrast Echo Final
52/80
The ProblemThe Problem
Over 5 million ED visits in US for chest pain (CP)Over 5 million ED visits in US for chest pain (CP)
Only 10Only 10--30% of them actually will have a AMI30% of them actually will have a AMI(acute MI)(acute MI)
EKG diagnoses onlyEKG diagnoses only
3030--40% of AMI40% of AMI Blood work,Blood work,
includingincludingtroponins,troponins,take time totake time toreturnreturn
Troponins takeTroponins takeseveral hoursseveral hoursdetect afterdetect afterinfarctioninfarction
8/2/2019 Contrast Echo Final
53/80
The Problem Part IIThe Problem Part II
When AMI is not immediately diagnosedWhen AMI is not immediately diagnosedfrom EKG, treatment is delayed untilfrom EKG, treatment is delayed untiltroponins turn positivetroponins turn positive
Many are admitted for rule out becauseMany are admitted for rule out becausetheir troponins are negative in EDtheir troponins are negative in ED
Cost for rule out admissions is $10 billionCost for rule out admissions is $10 billionin United Statesin United States
5% of pts with AMI are5% of pts with AMI areinadvertently dischargedinadvertently discharged
8/2/2019 Contrast Echo Final
54/80
Wouldnt It Be GreatWouldnt It Be Great
If there was a test immediatelyIf there was a test immediatelyavailable to diagnose or risk stratifyavailable to diagnose or risk stratifypatientspatients
Low risk patients could be safelyLow risk patients could be safelydischarged without admissiondischarged without admission
High risk patients could be admittedHigh risk patients could be admitted
to the appropriate level of care andto the appropriate level of care andtreatedtreated
8/2/2019 Contrast Echo Final
55/80
The ContendersThe Contenders
There are a number of imagingThere are a number of imagingmodalities that try to address thismodalities that try to address thisproblemproblem
Traditional EchoTraditional Echo SPECTSPECT
CTCT
MRMR
Each provides important informationEach provides important informationbut has significant downsidesbut has significant downsides
8/2/2019 Contrast Echo Final
56/80
Traditional EchoTraditional Echo
8/2/2019 Contrast Echo Final
57/80
Traditional EchoTraditional Echo
Traditional echocardiography is used to diagnoseTraditional echocardiography is used to diagnoseAMI by analyzing regional wall thickening andAMI by analyzing regional wall thickening andhypokinesishypokinesis
In patients presenting to the ED with CP and nonIn patients presenting to the ED with CP and non--
diagnostic EKG, specificity is only 53diagnostic EKG, specificity is only 53--57% for57% forAMI and 78% for cardiac ischemiaAMI and 78% for cardiac ischemia
FalseFalse--negative studiesnegative studiesreported in 1% of ptsreported in 1% of ptswith AMIwith AMI
Poor image quality,Poor image quality,especially in patientsespecially in patientswith suboptimalwith suboptimalwindowswindows
8/2/2019 Contrast Echo Final
58/80
SPECTSPECT
Non-transmural MI with stress induced ischemia
8/2/2019 Contrast Echo Final
59/80
SPECTSPECT
TechnetiumTechnetium--99 used to evaluate myocardial99 used to evaluate myocardialblood flow (MBF) several hours after injectionblood flow (MBF) several hours after injection
Effective at reducing rule out admissions by 32%Effective at reducing rule out admissions by 32%
Studies show good sensitivity and negativeStudies show good sensitivity and negative
predictive value but performed using lowpredictive value but performed using low--riskriskpatients and using CK or CKpatients and using CK or CK--MB as gold standardMB as gold standard
33--4% of LV myocardium must be affected before4% of LV myocardium must be affected beforeperfusion defect visibleperfusion defect visible
Hence small troponinHence small troponin--positive AMIs missedpositive AMIs missed SPECT unable to differentiate between old andSPECT unable to differentiate between old and
new infarctionsnew infarctions
Downsides also include isotope issues and needDownsides also include isotope issues and needfor study to be performed in Nuc Med deptfor study to be performed in Nuc Med dept
8/2/2019 Contrast Echo Final
60/80
CTCT
Multidetector CT showing a high-grade proximal LAD stenosis
8/2/2019 Contrast Echo Final
61/80
CTCT
Benefits of being able to examine coronaryBenefits of being able to examine coronaryanatomy, vessel stenosis, vessel remodeling,anatomy, vessel stenosis, vessel remodeling,ventricular function and to exclude other seriousventricular function and to exclude other seriouscauses of CPcauses of CP
CT with calcium score good at diagnosing CADCT with calcium score good at diagnosing CADbut not whether CAD is causing CPbut not whether CAD is causing CP
Difficult to evaluateDifficult to evaluatemyocardium in the settingmyocardium in the settingof tachycardia and previousof tachycardia and previous
stent placementstent placement Difficult to evaluate smallDifficult to evaluate small
arteriesarteries
Pts exposed to radiationPts exposed to radiationand contrastand contrast
8/2/2019 Contrast Echo Final
62/80
Cardiac Magnetic ResonanceCardiac Magnetic Resonance
Sub-endocardial infarction in inferior left ventricular wall
8/2/2019 Contrast Echo Final
63/80
Cardiac Magnetic ResonanceCardiac Magnetic Resonance
IV Gadolinium used to assess myocardialIV Gadolinium used to assess myocardialperfusion, wall motion abnormalities andperfusion, wall motion abnormalities andcoronary anatomycoronary anatomy
Benefits of high resolution, no radiation,Benefits of high resolution, no radiation,
no nephrotoxic contrastno nephrotoxic contrast Drawbacks include motion artifact limitingDrawbacks include motion artifact limiting
evaluation of small arteries, limitedevaluation of small arteries, limitedavailability of MR machinery, unsuitableavailability of MR machinery, unsuitablefor patients with pacemakers and ptfor patients with pacemakers and ptclaustrophobiaclaustrophobia
Sensitivity 72% and specificitySensitivity 72% and specificity87% compared to angiography87% compared to angiography
8/2/2019 Contrast Echo Final
64/80
We Need Something BetterWe Need Something Better
Ideal imaging modality would be:Ideal imaging modality would be: SafeSafe
Highly specific and sensitiveHighly specific and sensitive
Having high negative and positive predictive valuesHaving high negative and positive predictive values
Not hampered by cardiac motionNot hampered by cardiac motion Able to be performed and interpreted at all hoursAble to be performed and interpreted at all hours
Widely availableWidely available
QuickQuick
NonNon--invasiveinvasive
RadiationRadiation--freefree
PortablePortable
InexpensiveInexpensive
8/2/2019 Contrast Echo Final
65/80
Introducing CEIntroducing CE
Contrast EchocardiographyContrast Echocardiography
Many benefits including:Many benefits including: SafetySafety
High specificity, sensitivity, negative predictiveHigh specificity, sensitivity, negative predictivevalue,value,
Good visualization despite cardiac motionGood visualization despite cardiac motion
Echo equipment is widely availableEcho equipment is widely available
QuickQuick
NonNon--invasiveinvasive
RadiationRadiation--freefree
PortablePortable
InexpensiveInexpensive
8/2/2019 Contrast Echo Final
66/80
SideSide--ByBy--Side CE, SPECT, MRSide CE, SPECT, MR
Fixed septal/apical perfusion defectFixed septal/apical perfusion defectafter MI (arrows) with CE (left),after MI (arrows) with CE (left),SPECT (middle), and delayedSPECT (middle), and delayedenhancement with MR (right)enhancement with MR (right)
8/2/2019 Contrast Echo Final
67/80
How It WorksHow It Works
Inject IV microbubblesInject IV microbubbles
Microbubbles remain exclusivelyMicrobubbles remain exclusivelyintravascular and opacity systemicintravascular and opacity systemiccirculationcirculation
Evaluate wall motion with traditionalEvaluate wall motion with traditionalecho techniquesecho techniques
Evaluate myocardial perfusionEvaluate myocardial perfusion(described in a future slide)(described in a future slide)
8/2/2019 Contrast Echo Final
68/80
About The MicrobubblesAbout The Microbubbles
About 3 m in diameterAbout 3 m in diameter
(Smaller than RBC)(Smaller than RBC)
Contain gases of low diffusibility and solubilityContain gases of low diffusibility and solubility
Hemodynamically inertHemodynamically inert Microvascular rheologyMicrovascular rheology
identical to RBCsidentical to RBCs (Rheology is the study(Rheology is the study
of the deformation andof the deformation and
flow of matter under theflow of matter under theinfluence of an appliedinfluence of an appliedstress.)stress.)
8/2/2019 Contrast Echo Final
69/80
(Regional Function) RF(Regional Function) RF
Easier to determine RF with CE thanEasier to determine RF with CE thantraditional echo because endocardialtraditional echo because endocardialborders are delineated in muchborders are delineated in much
greater detailgreater detail Even smaller wall motion defects areEven smaller wall motion defects are
identifiable than with traditional echoidentifiable than with traditional echo
Interpreter confidence is increasedInterpreter confidence is increased
Interobserver and intraobserverInterobserver and intraobservervariability is decreasedvariability is decreased
8/2/2019 Contrast Echo Final
70/80
RF and Time DelayRF and Time Delay
The Dogma is that RF will only beThe Dogma is that RF will only beabnormal in the setting of active CPabnormal in the setting of active CP
The data show RF abnormalities persistThe data show RF abnormalities persist
after resolution of CP in NSTEMI, unstableafter resolution of CP in NSTEMI, unstableangina and transient ischemia because of:angina and transient ischemia because of:
Patchy microvascular and myocellular necrosisPatchy microvascular and myocellular necrosis
Subocclusive disease with severe decreases inSubocclusive disease with severe decreases in
perfusionperfusion Myocardial stunning after spontaneousMyocardial stunning after spontaneous
reperfusionreperfusion
8/2/2019 Contrast Echo Final
71/80
MBFMBF
After regional function is analyzed, highAfter regional function is analyzed, high--energy ultrasound is used to destroy theenergy ultrasound is used to destroy themicrobubblesmicrobubbles
How quickly microbubbles return dependsHow quickly microbubbles return dependson RBC velocityon RBC velocity
Microbubbles will return in 5 seconds inMicrobubbles will return in 5 seconds innormal myocardiumnormal myocardium
If microbubbles do not return in 5 secondsIf microbubbles do not return in 5 secondsthen myocardial perfusion is decreasedthen myocardial perfusion is decreased
8/2/2019 Contrast Echo Final
72/80
Another ImageAnother Image
Pt with recent AMIPt with recent AMIand occluded Cx.and occluded Cx.MP defects can beMP defects can be
seen at the lateralseen at the lateralapex and middleapex and middlelateral walllateral wall
8/2/2019 Contrast Echo Final
73/80
The Data: CE vs TIMIThe Data: CE vs TIMI
Pts presenting to ED with CP and nonPts presenting to ED with CP and non--diagnostic EKG:diagnostic EKG: CE with RF and MP is superior to TIMI score,CE with RF and MP is superior to TIMI score,
both with and without troponin values, inboth with and without troponin values, in
providing shortproviding short--, intermediate, intermediate-- and longand long--termtermprognostic informationprognostic information
(TIMI is Thrombolysis in MI scoring system(TIMI is Thrombolysis in MI scoring system
based on age, coronary risk factors, knownbased on age, coronary risk factors, knowncoronary stenosis, ST segment deviation, twocoronary stenosis, ST segment deviation, twoor more angina events in previous 24 hrs, useor more angina events in previous 24 hrs, useof ASA in previous week, elevated troponin)of ASA in previous week, elevated troponin)
8/2/2019 Contrast Echo Final
74/80
Visual DataVisual Data
Incremental value of tests performedIncremental value of tests performed
for determining risk of all eventsfor determining risk of all events
D=Demographics, C=Clinical, E=EKGD=Demographics, C=Clinical, E=EKG
8/2/2019 Contrast Echo Final
75/80
The Data: Effect of Time DelayThe Data: Effect of Time Delay
Patients presenting to ED within 12Patients presenting to ED within 12hours of CP with nonhours of CP with non--diagnostic EKG:diagnostic EKG:
No difference in detection of RF or MPNo difference in detection of RF or MP
abnormalities between pts with ongoingabnormalities between pts with ongoingCP and resolved CPCP and resolved CP
Time delay does not affect CEs abilityTime delay does not affect CEs abilityto predict events within 24 hoursto predict events within 24 hours
8/2/2019 Contrast Echo Final
76/80
The DownsidesThe Downsides
Smallest AMIs (about 1%) will be missedSmallest AMIs (about 1%) will be missed These patients also had short duration of CPThese patients also had short duration of CP
and low troponin peaksand low troponin peaks
Positive predictive value only 34%Positive predictive value only 34%because old deficits unable to bebecause old deficits unable to bedifferentiated from new deficitsdifferentiated from new deficits PPV 98% if pts with previous of AMI excludedPPV 98% if pts with previous of AMI excluded
Techs and MDs must be available toTechs and MDs must be available toperform and interpret exams at all hoursperform and interpret exams at all hours
Interpretation is subjectiveInterpretation is subjective
8/2/2019 Contrast Echo Final
77/80
Example of CE in UseExample of CE in Use
81 yo man with well81 yo man with well--controlled HTN andcontrolled HTN andno prior cardiac hxno prior cardiac hx
Presents to ED with one hour of substernalPresents to ED with one hour of substernal
CP, SOB, cramping in left armCP, SOB, cramping in left arm Occurred after eating and not duringOccurred after eating and not during
significant exertionsignificant exertion
Normal PE, EKG, CXR,Normal PE, EKG, CXR,first troponinfirst troponin
CE performed in EDCE performed in ED
8/2/2019 Contrast Echo Final
78/80
CE Saves The DayCE Saves The Day
CE in ED showed:CE in ED showed:
RF abnormality in mid and distal septum, anterior wallRF abnormality in mid and distal septum, anterior walland apexand apex
MP abnormality in same segments with gradual return ofMP abnormality in same segments with gradual return ofcontrast indicating significant residual myocardialcontrast indicating significant residual myocardial
viabilityviability Pt admitted to cardiology,Pt admitted to cardiology,
cath showed multicath showed multi--vesselvesseldisease, CABG performeddisease, CABG performedsuccessfullysuccessfully
Troponin was not positiveTroponin was not positiveuntil 8 hrs after presentationuntil 8 hrs after presentation
8/2/2019 Contrast Echo Final
79/80
Future Directions For CEFuture Directions For CE
New contrast agents being developedNew contrast agents being developedthat are targeted to inflammation,that are targeted to inflammation,angiogenesis, thrombosisangiogenesis, thrombosis
Presence of acute inflammation one wayPresence of acute inflammation one wayto differentiate new from old injuryto differentiate new from old injury
Use of new contrast agents may beUse of new contrast agents may be
expand contrast ultrasonography toexpand contrast ultrasonography toany organ accessible by ultrasoundany organ accessible by ultrasound
8/2/2019 Contrast Echo Final
80/80
THANK YOUTHANK YOU